
AIDS Prevention Deal Excludes Much of Latin America
July 9, 2025 WASHINGTON, D.C. – The Global Fund to Fight AIDS, Tuberculosis and Malaria today announced a deal with Gilead Sciences to purchase lenacapavir, a breakthrough long-acting injection for HIV prevention, for low- and middle-income countries. …